PriceTargets.com logo

Cognex - CGNX Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $45.53
  • Forecasted Upside: 17.05%
  • Number of Analysts: 18
  • Breakdown:
  • 2 Sell Ratings
  • 7 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$38.90 As of 12/4/2025 05:00 PM ET
▲ +1.21 (3.21%)

This chart shows the closing price for CGNX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cognex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CGNX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CGNX

Analyst Price Target is $45.53
▲ +17.05% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Cognex in the last 3 months. The average price target is $45.53, with a high forecast of $60.00 and a low forecast of $33.00. The average price target represents a 17.05% upside from the last price of $38.90.

This chart shows the closing price for CGNX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 18 polled investment analysts is to hold stock in Cognex. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 8 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 2 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/3/2025JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$45.00 ➝ $35.00
12/1/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/25/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/13/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
11/3/2025DA DavidsonSet TargetNeutral ➝ Neutral$35.00 ➝ $38.00
10/31/2025UBS GroupReiterated RatingBuy ➝ Buy$58.00
10/31/2025KeyCorpReiterated RatingOverweight ➝ Overweight$50.00
10/31/2025Robert W. BairdSet Target$45.00
10/31/2025BarclaysReiterated RatingOverweight ➝ Overweight$55.00 ➝ $56.00
10/31/2025Needham & Company LLCBoost TargetBuy ➝ Buy$45.00 ➝ $47.00
10/8/2025Truist FinancialSet TargetHold ➝ Hold$37.00 ➝ $45.00
10/8/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
10/7/2025BarclaysSet TargetOverweight$55.00
10/7/2025BarclaysUpgradeStrong-Buy
9/27/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/16/2025The Goldman Sachs GroupBoost TargetSell ➝ Sell$36.00 ➝ $40.00
9/15/2025JPMorgan Chase & Co.Initiated CoverageNeutral$45.00
8/4/2025DA DavidsonBoost TargetNeutral ➝ Neutral$32.00 ➝ $35.00
8/1/2025UBS GroupBoost TargetBuy ➝ Buy$53.00 ➝ $58.00
8/1/2025KeyCorpUpgradeSector Weight ➝ Overweight$50.00
7/31/2025Needham & Company LLCBoost TargetBuy ➝ Buy$36.00 ➝ $45.00
7/14/2025CitigroupReiterated RatingNeutral ➝ Neutral$30.00 ➝ $37.00
7/10/2025MeliusUpgradeHold ➝ Buy$60.00
6/16/2025DA DavidsonReiterated RatingNeutral ➝ Neutral$32.00
6/16/2025Robert W. BairdBoost TargetNeutral ➝ Neutral$30.00 ➝ $32.00
6/12/2025The Goldman Sachs GroupBoost TargetSell ➝ Sell$29.00 ➝ $32.00
6/11/2025Needham & Company LLCBoost TargetBuy ➝ Buy$33.00 ➝ $36.00
5/6/2025The Goldman Sachs GroupLower TargetSell ➝ Sell$33.00 ➝ $29.00
5/5/2025DA DavidsonLower TargetNeutral ➝ Neutral$35.00 ➝ $32.00
5/2/2025UBS GroupLower TargetBuy ➝ Buy$56.00 ➝ $53.00
5/1/2025Needham & Company LLCLower TargetBuy ➝ Buy$41.00 ➝ $33.00
4/28/2025CowenUpgradeHold ➝ Buy
4/28/2025TD CowenUpgradeHold ➝ Buy$35.00
4/14/2025CitigroupLower TargetNeutral ➝ Neutral$37.00 ➝ $26.00
4/8/2025Truist FinancialLower TargetHold ➝ Hold$37.00 ➝ $29.00
3/12/2025StephensReiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.00
2/21/2025Hsbc Global ResDowngradeStrong-Buy ➝ Hold
2/21/2025HSBCDowngradeBuy ➝ Hold$33.00
2/18/2025The Goldman Sachs GroupLower TargetSell ➝ Sell$39.00 ➝ $35.00
2/18/2025UBS GroupLower TargetBuy ➝ Buy$58.00 ➝ $56.00
2/18/2025Robert W. BairdLower TargetNeutral ➝ Neutral$42.00 ➝ $38.00
2/14/2025Truist FinancialReiterated RatingHold ➝ Hold$43.00 ➝ $37.00
2/14/2025Needham & Company LLCLower TargetBuy ➝ Buy$47.00 ➝ $41.00
1/16/2025Truist FinancialBoost TargetHold ➝ Hold$42.00 ➝ $43.00
1/13/2025CitigroupLower TargetNeutral ➝ Neutral$44.00 ➝ $42.00
1/2/2025StephensReiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.00
12/20/2024Cantor FitzgeraldUpgradeStrong-Buy
12/19/2024Cantor FitzgeraldInitiated CoverageOverweight$49.00
12/19/2024Truist FinancialLower TargetHold ➝ Hold$43.00 ➝ $42.00
11/5/2024Truist FinancialDowngradeBuy ➝ Hold$46.00 ➝ $43.00
11/1/2024Needham & Company LLCLower TargetBuy ➝ Buy$50.00 ➝ $47.00
10/16/2024StephensUpgradeEqual Weight ➝ Overweight$45.00 ➝ $55.00
8/5/2024DA DavidsonLower TargetNeutral ➝ Neutral$41.00 ➝ $39.00
8/5/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$45.00 ➝ $45.00
8/5/2024Robert W. BairdLower TargetNeutral ➝ Neutral$46.00 ➝ $42.00
8/2/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$45.00 ➝ $39.00
8/2/2024Truist FinancialLower TargetBuy ➝ Buy$55.00 ➝ $46.00
7/29/2024Needham & Company LLCBoost TargetBuy ➝ Buy$48.00 ➝ $57.00
7/23/2024Vertical ResearchInitiated CoverageBuy$58.00
7/2/2024Truist FinancialBoost TargetBuy ➝ Buy$50.00 ➝ $55.00
5/7/2024HSBCUpgradeHold ➝ Buy$52.00
5/7/2024Truist FinancialReiterated RatingBuy ➝ Buy$47.00 ➝ $50.00
5/6/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$36.00 ➝ $41.00
5/3/2024Sanford C. BernsteinBoost TargetOutperform ➝ Outperform$52.00 ➝ $55.00
5/3/2024StephensBoost TargetEqual Weight ➝ Equal Weight$40.00 ➝ $45.00
5/3/2024Robert W. BairdBoost TargetNeutral ➝ Neutral$40.00 ➝ $44.00
5/3/2024Needham & Company LLCBoost TargetBuy ➝ Buy$46.00 ➝ $48.00
4/8/2024CitigroupBoost TargetNeutral ➝ Neutral$41.00 ➝ $43.00
3/19/2024UBS GroupUpgradeNeutral ➝ Buy$42.00 ➝ $54.00
3/14/2024Truist FinancialInitiated CoverageBuy$47.00
11/6/2023Raymond James FinancialLower TargetStrong-Buy ➝ Strong-Buy$65.00 ➝ $60.00
11/2/2023StephensLower TargetEqual Weight ➝ Equal Weight$55.00 ➝ $40.00
11/1/2023Needham & Company LLCLower TargetBuy ➝ Buy$55.00 ➝ $46.00
10/10/2023The Goldman Sachs GroupLower TargetSell ➝ Sell$45.00 ➝ $40.00
10/5/2023BNP ParibasInitiated CoverageOutperform$55.00
10/2/2023KeyCorpInitiated CoverageSector Weight ➝ Sector Weight
9/1/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$55.00
8/30/2023CitigroupInitiated CoverageNeutral$52.00
8/7/2023Credit Suisse GroupLower TargetNeutral ➝ Neutral$47.00 ➝ $46.00
8/4/2023Morgan StanleyBoost TargetUnderweight ➝ Underweight$45.00 ➝ $46.00
8/3/2023Needham & Company LLCLower TargetBuy$58.00 ➝ $55.00
7/13/2023Credit Suisse GroupBoost Target$46.00 ➝ $47.00
6/23/2023CL KingInitiated CoverageNeutral
5/5/2023UBS GroupBoost Target$48.00 ➝ $52.00
2/23/2023Credit Suisse GroupUpgradeUnderperform ➝ Neutral$41.00 ➝ $44.00
2/21/2023StephensReiterated RatingEqual Weight$45.00
2/17/2023CowenLower Target$50.00 ➝ $48.00
2/17/2023Needham & Company LLCBoost TargetBuy$54.00 ➝ $58.00
2/1/2023Northcoast ResearchDowngradeBuy ➝ Neutral
1/17/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$41.00 ➝ $40.00
12/12/2022Credit Suisse GroupInitiated CoverageUnderperform$41.00
11/22/2022CowenDowngradeOutperform ➝ Market Perform$55.00 ➝ $50.00
11/22/2022CowenDowngradeOutperform ➝ Market Perform$55.00 ➝ $50.00
11/6/2022Raymond James FinancialLower Target$75.00 ➝ $65.00
11/4/2022Needham & Company LLCBoost TargetBuy$52.00 ➝ $54.00
10/12/2022Morgan StanleyLower TargetEqual Weight$45.00 ➝ $41.00
9/20/2022Needham & Company LLCBoost TargetBuy$50.00 ➝ $52.00
8/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$40.00
8/9/2022Daiwa Capital MarketsLower Target$54.00
8/4/2022Morgan StanleyLower TargetEqual Weight$52.00 ➝ $45.00
8/3/2022Raymond James FinancialLower TargetStrong-Buy$80.00 ➝ $75.00
8/3/2022CowenLower TargetOutperform$75.00 ➝ $55.00
8/3/2022CowenLower TargetOutperform$75.00 ➝ $55.00
8/3/2022StephensDowngradeOverweight ➝ Equal Weight$80.00 ➝ $45.00
8/3/2022Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$65.00
8/1/2022Needham & Company LLCLower TargetBuy$80.00 ➝ $60.00
6/23/2022The Goldman Sachs GroupLower TargetSell$59.00 ➝ $41.00
6/9/2022Raymond James FinancialLower Target$90.00 ➝ $80.00
5/31/2022Morgan StanleyLower TargetEqual Weight$68.00 ➝ $52.00
5/26/2022UBS GroupLower TargetNeutral$80.00 ➝ $50.00
5/10/2022CowenLower Target$95.00 ➝ $75.00
5/10/2022CowenLower Target$95.00 ➝ $75.00
4/7/2022Morgan StanleyBoost TargetEqual Weight$75.00 ➝ $80.00
3/7/2022The Goldman Sachs GroupLower TargetSell$77.00 ➝ $67.00
2/18/2022Needham & Company LLCReiterated RatingBuy$95.00
2/18/2022Morgan StanleyLower TargetEqual Weight$83.00 ➝ $75.00
2/18/2022DA DavidsonLower Target$85.00 ➝ $80.00
2/18/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$80.00 ➝ $68.00
1/25/2022Daiwa Capital MarketsUpgradeNeutral ➝ Buy$81.00 ➝ $75.00
1/14/2022Morgan StanleyLower TargetEqual Weight$85.00 ➝ $83.00
1/14/2022CowenLower Target$100.00 ➝ $95.00
11/12/2021CowenLower TargetOutperform$110.00 ➝ $100.00
11/12/2021Morgan StanleyUpgradeUnderweight ➝ Equal Weight$78.00 ➝ $85.00
11/8/2021Northcoast ResearchUpgradeNeutral ➝ Buy
11/8/2021Needham & Company LLCUpgradeHold ➝ Buy$95.00
11/8/2021Raymond James FinancialLower TargetStrong-Buy$120.00 ➝ $110.00
10/7/2021Morgan StanleyLower TargetUnderweight$79.00 ➝ $74.00
8/10/2021DA DavidsonReiterated RatingNeutral
8/6/2021HSBCDowngradeBuy ➝ Hold$92.00
8/6/2021Needham & Company LLCReiterated RatingHold
5/19/2021Raymond James FinancialUpgradeOutperform ➝ Strong-Buy$100.00 ➝ $120.00
5/7/2021Morgan StanleyBoost TargetUnderweight$68.00 ➝ $72.00
2/12/2021CowenBoost TargetOutperform$85.00 ➝ $105.00
2/12/2021Raymond James FinancialBoost TargetOutperform$75.00 ➝ $100.00
2/12/2021Morgan StanleyBoost TargetUnderweight$62.00 ➝ $68.00
1/20/2021Morgan StanleyBoost TargetUnderweight$57.00 ➝ $62.00
1/14/2021HSBCUpgradeHold ➝ Buy
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.06 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 39 very positive mentions
  • 21 positive mentions
  • 14 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 50 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
6/7/2025
  • 21 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 40 very positive mentions
  • 31 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
8/6/2025
  • 37 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 37 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 46 very positive mentions
  • 29 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 33 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 33 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cognex logo
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to automotive, logistics, consumer electronics, medical-related, semiconductor, consumer products, food and beverage, and others, as well as through a network of distributors and integrators. The company was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $38.90
Low: $37.55
High: $39.14

50 Day Range

MA: $42.09
Low: $34.86
High: $48.35

52 Week Range

Now: $38.90
Low: $22.67
High: $49.76

Volume

1,728,774 shs

Average Volume

1,607,488 shs

Market Capitalization

$6.52 billion

P/E Ratio

60.78

Dividend Yield

0.90%

Beta

1.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Cognex?

The following Wall Street analysts have issued reports on Cognex in the last year: Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Cowen Inc, DA Davidson, Hsbc Global Res, HSBC Holdings plc, JPMorgan Chase & Co., KeyCorp, Melius, Needham & Company LLC, Robert W. Baird, Stephens, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, and Weiss Ratings.
View the latest analyst ratings for CGNX.

What is the current price target for Cognex?

0 Wall Street analysts have set twelve-month price targets for Cognex in the last year. Their average twelve-month price target is $45.53, suggesting a possible upside of 17.1%. Melius has the highest price target set, predicting CGNX will reach $60.00 in the next twelve months. HSBC Holdings plc has the lowest price target set, forecasting a price of $33.00 for Cognex in the next year.
View the latest price targets for CGNX.

What is the current consensus analyst rating for Cognex?

Cognex currently has 2 sell ratings, 7 hold ratings, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CGNX, but not buy more shares or sell existing shares.
View the latest ratings for CGNX.

What other companies compete with Cognex?

Other companies that are similar to Cognex include Trimble, Zebra Technologies, Badger Meter, OSI Systems and Itron. Learn More about companies similar to Cognex.

How do I contact Cognex's investor relations team?

Cognex's physical mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company's listed phone number is (508) 650-3000 and its investor relations email address is [email protected]. The official website for Cognex is www.cognex.com. Learn More about contacing Cognex investor relations.